UK and Switzerland collaborate to shape the future of space-enabled pharmaceuticals
UK and Switzerland collaborate to shape the future of space-enabled pharmaceuticals
Microgravity research is creating new opportunities for discovering and manufacturing medicines in space. The pharmaceutical industry spends around $300 billion annually on R&D, meaning even modest gains in efficiency or success rates could yield significant economic returns. These advances have the potential to both accelerate the development of new medicines and deliver substantial benefits to …
